Novartis AG (NVSEF)
99.54
+3.27
(+3.40%)
USD |
OTCM |
May 08, 11:55
Novartis Profit Margin (Quarterly): 22.18% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 22.18% |
December 31, 2023 | 72.01% |
September 30, 2023 | 14.56% |
June 30, 2023 | 16.62% |
March 31, 2023 | 20.76% |
December 31, 2022 | 13.37% |
September 30, 2022 | 14.59% |
June 30, 2022 | 12.95% |
March 31, 2022 | 17.34% |
December 31, 2021 | |
September 30, 2021 | 20.63% |
June 30, 2021 | 21.78% |
March 31, 2021 | 16.22% |
December 31, 2020 | 16.07% |
September 30, 2020 | 15.43% |
June 30, 2020 | 16.06% |
March 31, 2020 | 17.12% |
December 31, 2019 | 8.85% |
September 30, 2019 | 16.36% |
June 30, 2019 | 56.55% |
March 31, 2019 | 15.42% |
December 31, 2018 | 10.04% |
September 30, 2018 | 14.25% |
June 30, 2018 | 66.66% |
March 31, 2018 | 18.14% |
Date | Value |
---|---|
December 31, 2017 | 30.72% |
September 30, 2017 | 16.40% |
June 30, 2017 | 15.85% |
March 31, 2017 | 14.14% |
December 31, 2016 | 7.59% |
September 30, 2016 | 15.72% |
June 30, 2016 | 14.23% |
March 31, 2016 | 17.03% |
December 31, 2015 | 8.23% |
September 30, 2015 | 15.12% |
June 30, 2015 | 14.24% |
March 31, 2015 | |
December 31, 2014 | 11.17% |
September 30, 2014 | 24.23% |
June 30, 2014 | 18.32% |
March 31, 2014 | 22.57% |
December 31, 2013 | 14.89% |
September 30, 2013 | 17.29% |
June 30, 2013 | 18.95% |
March 31, 2013 | 16.88% |
December 31, 2012 | 20.94% |
September 30, 2012 | 17.02% |
June 30, 2012 | 18.21% |
March 31, 2012 | 16.15% |
December 31, 2011 | 6.68% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
8.85%
Minimum
Dec 2019
72.01%
Maximum
Dec 2023
21.55%
Average
16.36%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
Sandoz Group AG | -- |
Roche Holding AG | -- |
Bristol-Myers Squibb Co | -100.4% |
ADC Therapeutics SA | -510.4% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 33.31% |
Return on Assets | 14.38% |
Return on Invested Capital | 21.39% |
Gross Profit Margin (Quarterly) | 74.46% |
Operating Margin (Quarterly) | 27.83% |
Return on Net Operating Assets | 18.86% |